Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Factor VIII Deficiency, Congenital”

245 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 245 results

Post-approval studies (Phase 4)WithdrawnNCT00151385
What this trial is testing

Study Evaluating Inhibitor Specificity in Hemophilia A

Who this might be right for
Hemophilia A
Wyeth is now a wholly owned subsidiary of Pfizer
Not applicableStudy completedNCT01959555
What this trial is testing

Project to Update the Study of Congenital Haemophilia in Spain

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B
Novo Nordisk A/S 1,157
Not applicableStudy completedNCT02300519
What this trial is testing

Thrombin Generation Numerical Models Validation in Haemophilic Case

Who this might be right for
Haemophilia BHaemophilia A
Centre Hospitalier Universitaire de Saint Etienne 40
Post-approval studies (Phase 4)Looking for participantsNCT04567511
What this trial is testing

Hemlibra in Mild Hemophilia A

Who this might be right for
Factor VIII Deficiency, Congenital
Indiana Hemophilia &Thrombosis Center, Inc. 20
Not applicableStudy completedNCT00002276
What this trial is testing

The Effects of AZT and Ibuprofen on HIV-Infected Patients With Hemophilia

Who this might be right for
HIV InfectionsHemophilia A
University of Pittsburgh
Post-approval studies (Phase 4)Study completedNCT00108797
What this trial is testing

Trial of NovoSeven® in Haemophilia - Joint Bleeds

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors
Novo Nordisk A/S 42
Not applicableStudy completedNCT02093741
What this trial is testing

ADVATE 2 mL Post-Authorization Safety Surveillance (PASS)

Who this might be right for
Hemophilia ACongenital Factor VIII (FVIII) Deficiency
Baxalta now part of Shire 65
Not applicableStudy completedNCT02976753
What this trial is testing

Prospective, Non-interventional Study to Evaluate the Effectiveness of Elocta Compared to Conventional Factor Products

Who this might be right for
Hemophilia A
Swedish Orphan Biovitrum 361
Not applicableStudy completedNCT02241694
What this trial is testing

To Quantify the Range of Main Psychosocial Factors Affecting Patients and Caregivers in Their Daily Lives

Who this might be right for
Congenital Bleeding DisorderHaemophilia AHaemophilia B+3 more
Novo Nordisk A/S 200
Large-scale testing (Phase 3)Study completedNCT00840086
What this trial is testing

Safety and Efficacy of Turoctocog Alfa in Haemophilia A Subjects

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 150
Not applicableStudy completedNCT03876301
What this trial is testing

Lead-in Study to Collect Prospective Efficacy and Safety Data of Current FVIII Prophylaxis Replacement Therapy in Adult Hemophilia A Participants

Who this might be right for
Blood Coagulation DisorderBlood Coagulation Disorders, InheritedCoagulation Protein Disorders+6 more
Spark Therapeutics, Inc. 25
Early research (Phase 1)Study completedNCT02920398
What this trial is testing

A Multi-centre, Comparative, Double Blind, Randomised Cross-over Trial Investigating Single Dose Pharmacokinetics and Safety of Turoctocog Alfa Pegol From the Pivotal Process and Turoctocog Alfa Pegol From the Commercial Process in Patients With Severe Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 21
Large-scale testing (Phase 3)Study completedNCT05053139
What this trial is testing

A Research Study Investigating Mim8 in Adults and Adolescents With Haemophilia A With or Without Inhibitors

Who this might be right for
Haemophilia AHaemophilia A With Inhibitors
Novo Nordisk A/S 281
Early research (Phase 1)Study completedNCT01563471
What this trial is testing

Safety and Tolerability of Intravenous Doses of Activated Recombinant Human Factor VII in Healthy Volunteers

Who this might be right for
Congenital Bleeding DisorderHaemophilia A With InhibitorsHaemophilia B With Inhibitors+1 more
Novo Nordisk A/S 39
Not applicableStudy completedNCT02796222
What this trial is testing

Factor Product Utilization and Health Outcomes in Patients With Hemophilia

Who this might be right for
Hemophilia A, CongenitalHemophilia B, Congenital
University of British Columbia 61
Testing effectiveness (Phase 2)Study completedNCT03734588
What this trial is testing

Dose-finding Study of SPK-8016 Gene Therapy in Patients With Hemophilia A to Support Evaluation in Individuals With FVIII Inhibitors

Who this might be right for
Adeno-Associated Virus (AAV)Blood Coagulation DisorderBlood Coagulation Disorders, Inherited+14 more
Spark Therapeutics, Inc. 4
Not applicableLooking for participantsNCT02207894
What this trial is testing

A Survey on the Success of Inhibitor Elimination Using Individualized Concentrate Selection and Controlled ITI

Who this might be right for
Haemophilia A
Haemophilia Centre Rhine Main 300
Testing effectiveness (Phase 2)Study completedNCT00055341
What this trial is testing

Treatment of Hepatitis C in Hemophilic Patients With HIV

Who this might be right for
HIV InfectionsHepatitis CHemophilia
National Institute of Allergy and Infectious Diseases (NIAID) 22
Early research (Phase 1)Study completedNCT01692925
What this trial is testing

Investigation of the Pharmacokinetics of Turoctocog Alfa in Subjects With Haemophilia A

Who this might be right for
Congenital Bleeding DisorderHaemophilia A
Novo Nordisk A/S 15
Not applicableLooking for participantsNCT06684314
What this trial is testing

Evaluate Impact of Efanesoctocog Alfa on Long-term Joint Health in Participants With Hemophilia A in Taiwan

Who this might be right for
Hemophilia A
Sanofi 100
Load More Results